Bonesupport Holding AB
Bonesupport Holding AB (publ), an orthobiologics company, develops and sells injectable bio-ceramic bone graft substitutes in Europe, North America, and internationally. The company provides CERAMENT Bone Void Filler, an injectable ceramic bone graft substitute that remodels to host bone; CERAMENT G, an injectable ceramic bone graft substitute that remodels to host bone and elutes Gentamicin duri… Read more
Bonesupport Holding AB (BONEX) - Cash Flow Conversion Efficiency
Latest cash flow conversion efficiency as of September 2025: 0.085x
Based on the latest financial reports, Bonesupport Holding AB (BONEX) has a cash flow conversion efficiency ratio of 0.085x as of September 2025.
Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (Skr71.09 Million) by net assets (Skr835.89 Million). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations.
Bonesupport Holding AB - Cash Flow Conversion Efficiency Trend (2014–2024)
This chart illustrates how Bonesupport Holding AB's cash flow conversion efficiency has evolved over time, based on yearly financial data. Explore and compare other companies by cash flow conversion efficiency.
Bonesupport Holding AB Competitors by Cash Flow Conversion Efficiency
The table below lists competitors of Bonesupport Holding AB ranked by their cash flow conversion efficiency.
| Company | Cash Flow Conversion Efficiency |
|---|---|
|
MapLight Therapeutics, Inc. Common Stock
NASDAQ:MPLT
|
-0.136x |
|
Foran Mining Corporation
OTCQX:FMCXF
|
0.000x |
|
Eastcompeace Technology Co Ltd
SHE:002017
|
0.079x |
|
Alliance Material Co., Ltd.
TWO:3595
|
0.027x |
|
Wonik Holdings Co. Ltd
KQ:030530
|
0.029x |
|
REPT BATTERO Energy Co., Ltd.
F:L52
|
N/A |
|
Yuanbao Inc. American Depositary Shares
NASDAQ:YB
|
0.093x |
|
Sichuan Lutianhua Co Ltd
SHE:000912
|
0.001x |
Annual Cash Flow Conversion Efficiency for Bonesupport Holding AB (2014–2024)
The table below shows the annual cash flow conversion efficiency of Bonesupport Holding AB from 2014 to 2024.
| Year | Net Assets | Operating Cash Flow | Cash Flow Conversion Efficiency | Change |
|---|---|---|---|---|
| 2024-12-31 | Skr727.46 Million | Skr65.76 Million | 0.090x | +369.93% |
| 2023-12-31 | Skr545.18 Million | Skr-18.26 Million | -0.033x | +80.83% |
| 2022-12-31 | Skr268.93 Million | Skr-46.98 Million | -0.175x | +44.35% |
| 2021-12-31 | Skr265.70 Million | Skr-83.42 Million | -0.314x | -24.90% |
| 2020-12-31 | Skr398.90 Million | Skr-100.28 Million | -0.251x | +80.93% |
| 2019-12-31 | Skr124.31 Million | Skr-163.83 Million | -1.318x | -113.88% |
| 2018-12-31 | Skr278.53 Million | Skr-171.62 Million | -0.616x | -158.30% |
| 2017-12-31 | Skr450.79 Million | Skr-107.53 Million | -0.239x | +90.01% |
| 2016-12-31 | Skr34.30 Million | Skr-81.93 Million | -2.388x | +25.64% |
| 2015-12-31 | Skr20.33 Million | Skr-65.29 Million | -3.212x | -404.36% |
| 2014-12-31 | Skr-43.52 Million | Skr-45.92 Million | 1.055x | -- |